Pharmaceutical companies including Gilead Sciences Inc. and Sanofi kept secret more than a third of all clinical trial results for 15 drugs approved in 2012, according to a study, failing to publish data that could tip off doctors and patients to potentially dangerous side effects.
Twelve drugmakers released a median of 65 percent of relevant clinical trial findings for the selected treatments, according to the study, published Thursday in the medical journal BMJ Open. All of the drugs were approved by the U.S. Food and Drug Administration, which saw all of the human trials before granting clearance.
[...]
For Gilead’s HIV drug Stribild [...] only 21 percent of the clinical trial are publicly available, and Sanofi reported or published 22 percent of trials for its multiple sclerosis treatment Aubagio.
Bloomberg
...but hey, do what you want...you will anyway.
No comments:
Post a Comment